Description: This textbook titled "Orphan Drugs: Understanding the Rare Disease Market and Its Dynamics" provides valuable insights into the marketing of rare disease drugs. It was published in 2013 by Elsevier Science & Technology as part of the Woodhead Publishing Series in Biomedicine Ser. The authors, Elizabeth Hernberg-Sthl and Miroslav Reljanovi, present a comprehensive analysis of the rare disease market and the challenges faced by pharmaceutical companies in developing drugs for these conditions. The book is a hardcover edition with 334 pages and measures 9.2 inches in length, 6.1 inches in width, and 0.8 inches in height. It is written in English and has an ISBN-10 number of 1907568093. This textbook covers various aspects of the rare disease market and is suitable for students, researchers, and professionals in the pharmaceutical industry.
Price: 120 USD
Location: Hedgesville, West Virginia
End Time: 2024-11-27T03:46:57.000Z
Shipping Cost: 5.38 USD
Product Images
Item Specifics
All returns accepted: ReturnsNotAccepted
Book Title: Orphan Drugs: Understanding the Rare Disease Market and its
ISBN-10: 1907568093
Subject: Marketing
Item Length: 9.2in
Item Height: 0.8in
Item Width: 6.1in
Author: Elizabeth Hernberg-Ståhl, Miroslav Reljanović
Publication Name: Orphan Drugs : Understanding the Rare Disease Market and Its Dynamics
Format: Hardcover
Language: English
Publisher: Elsevier Science & Technology
Series: Woodhead Publishing Series in Biomedicine Ser.
Publication Year: 2013
Type: Textbook
Item Weight: 22.9 Oz
Number of Pages: 334 Pages
